Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries

dc.authorid0000-0002-7555-6201
dc.authorid0000-0001-6150-0066
dc.authorid0000-0002-3772-5588
dc.authorid0000-0002-3073-6890
dc.authorid0000-0002-8356-3137
dc.authorid0000-0003-4693-0038
dc.authorid0000-0001-7063-3354
dc.contributor.authorCorsi, Daniel J.
dc.contributor.authorSubramanian, S. V.
dc.contributor.authorChow, Clara K.
dc.contributor.authorMckee, Martin
dc.contributor.authorChifamba, Jephat
dc.contributor.authorDagenais, Giles
dc.contributor.authorDiaz, Rafael
dc.date.accessioned2025-05-10T19:48:19Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground The PURE study was established to investigate associations between social, behavioural, genetic, and environmental factors and cardiovascular diseases in 17 countries. In this analysis we compare the age, sex, urban/rural, mortality, and educational profiles of the PURE participants to national statistics. Methods PURE employed a community-based sampling and recruitment strategy where urban and rural communities were selected within countries. Within communities, representative samples of adults aged 35 to 70 years and their household members (n = 424,921) were invited for participation. Results The PURE household population compared to national statistics had more women (sex ratio 95.1 men per 100 women vs 100.3) and was older (33.1 years vs 27.3), although age had a positive linear relationship between the two data sources (Pearson's r = 0.92). PURE was 59.3% urban compared to an average of 63.1% in participating countries. The distribution of education was less than 7% different for each category, although PURE households typically had higher levels of education. For example, 37.8% of PURE household members had completed secondary education compared to 31.3% in the national data. Age-adjusted annual mortality rates showed positive correlation for men (r = 0.91) and women (r = 0.92) but were lower in PURE compared to national statistics (7.9 per 1000 vs 8.7 for men; 6.7 vs 8.1 for women). Conclusions These findings indicate that modest differences exist between the PURE household population and national data for the indicators studied. These differences, however, are unlikely to have much influence on exposure-disease associations derived in PURE. Further, incidence estimates from PURE, stratified according to sex and/or urban/rural location will enable valid comparisons of the relative rates of various cardiovascular outcomes across countries.
dc.description.sponsorshipMary W Burke endowed chair of the Heart and Stroke Foundation of Ontario; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia; Sydney Medical Foundation; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario; Astra Zeneca (Sweden); Astra Zeneca (Canada); Novartis (France); Sanofi-Aventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; King Pharma; GSK; Colombia: Colciencias [6566-04-18062]; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia [07-05-IFN-MEB010]; Bangladesh: Independent University, Bangladesh, Mitra and Associates; Brazil: Unilever Health Institute, Brazil Canada : Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Poland: Polish Ministry of Science and Higher Education [290/WPURE/2008/0]; Wroclaw Medical University; South Africa: The North-West University; SANPAD (SA and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of SA; SA Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); Sweden: Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LUA Agreement; Vastra Gotaland Region (FOUU); TURKEY: Metabolic Syndrome Society; Astra Zeneca, Turkey; TurkeySanofi Aventis, Turkey; UAE: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority; Dubai UAE
dc.description.sponsorshipS Yusuf is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. CK Chow is supported by a fellowship co-funded by the National Heart and Medical Research Council of Australia, National Heart Foundation of Australia, and Sydney Medical Foundation.The PURE study is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies [with major contributions from Astra Zeneca (Sweden and Canada), Novartis, Sanofi-Aventis(France and Canada), Boehringer Ingelheim (Germany & Canada), Servier, King Pharma, GSK], and additionally by various national bodies in different countries: Bangladesh: Independent University, Bangladesh, Mitra and Associates; Brazil: Unilever Health Institute, Brazil Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias, Grant number: 6566-04-18062; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia: Grant Number 07-05-IFN-MEB010, Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); Poland: Polish Ministry of Science and Higher Education grant Nr 290/WPURE/2008/0, Wroclaw Medical University; South Africa: The North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of SA, The SA Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden: Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LUA Agreement, Grant from the Vastra Gotaland Region (FOUU); TURKEY: Metabolic Syndrome Society, Astra Zeneca, Turkey, Sanofi Aventis, Turkey; UAE: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai UAE.
dc.identifier.doi10.1016/j.ahj.2013.04.019
dc.identifier.endpage+
dc.identifier.issn0002-8703
dc.identifier.issn1097-6744
dc.identifier.issue4
dc.identifier.pmid24093842
dc.identifier.scopus2-s2.0-84885179663
dc.identifier.scopusqualityQ1
dc.identifier.startpage636
dc.identifier.urihttps://doi.org/10.1016/j.ahj.2013.04.019
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11676
dc.identifier.volume166
dc.identifier.wosWOS:000325092300016
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMosby-Elsevier
dc.relation.ispartofAmerican Heart Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleProspective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11676.pdf
Boyut:
4.45 MB
Biçim:
Adobe Portable Document Format